Why Xeris Pharmaceuticals Is Soaring 7% Higher Today
Shares of Xeris Pharmaceuticals (NASDAQ: XERS) were jumping 7% higher heading into noontime trading Friday after analyst coverage of the specialty biopharma began the day with a buy rating.
H.C. Wainwright analyst Oren Livnat also assigned a $4-per-share price target on Xeris, which is more than double where the stock closed yesterday.
Image source: Getty Images.
Source Fool.com
